# Marginal Zone Lymphoma Cohort in Korea

> **NCT02732236** · — · UNKNOWN · sponsor: **Dong-A University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Lymphoma, B-Cell, Marginal Zone

## Interventions

- **OTHER:** Rituximab

## Key facts

- **NCT ID:** NCT02732236
- **Lead sponsor:** Dong-A University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2020-02
- **Final completion:** 2022-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02732236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02732236, "Marginal Zone Lymphoma Cohort in Korea". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02732236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*